↓ Skip to main content

Dove Medical Press

HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo

Overview of attention for article published in Drug Design, Development and Therapy, March 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
34 Mendeley
Title
HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo
Published in
Drug Design, Development and Therapy, March 2017
DOI 10.2147/dddt.s129913
Pubmed ID
Authors

Shuang Jiang, Xiaolong Chen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 18%
Other 4 12%
Student > Doctoral Student 4 12%
Student > Ph. D. Student 3 9%
Researcher 3 9%
Other 2 6%
Unknown 12 35%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 21%
Medicine and Dentistry 5 15%
Agricultural and Biological Sciences 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Computer Science 1 3%
Other 4 12%
Unknown 12 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2024.
All research outputs
#8,702,820
of 25,784,004 outputs
Outputs from Drug Design, Development and Therapy
#660
of 2,281 outputs
Outputs of similar age
#129,540
of 325,494 outputs
Outputs of similar age from Drug Design, Development and Therapy
#18
of 51 outputs
Altmetric has tracked 25,784,004 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,281 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,494 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.